NOVO — Marts 2026
-
Setting the record straight on obesity and Novo Nordisk’s obesity pill
An open letter from Mike Doustdar, President & CEO, Novo Nordisk https://www.novonordisk.com/news-and-media/latest-news/setting-record-straight-on-obesity-and-novo-nordisks-obesity-pill.html -
MedWatch + Børsen “Rådgivningsfirma fraråder opbakning til genvalg af Rebien som formand“ - Forud for Novos GF ultimo marts, anbefaler aktionærrådgivningsfirmaet Institutional Shareholder Services, ISS, at stemme på andre end Lars Rebien, ifølge Bloomberg News. https://borsen.dk/nyheder/generelt/novo-radgivningsfirma-frarader-opbakning-til-genvalg-af-rebien-som-formand
-
@16.57 CC. Doustar er jo lige startet - ingen analytiker kan vel forudsige hvad der sker kommende år med sikkerhed og om analytikerne får tillid til Doustar. Hvis de nedjustere i.f.m Q1 er det selvfølgelig op ad bakke men en opjustering efter Q1 eller senere vil vel være positivt og give Doustar medvind - har ikke adgang til artiklen
-
NEW: In a study of 600,000 people published today in @bmj_latest
, we found GLP-1 drugs (Ozempic, Wegovy, Mounjaro) associated with reduced risk of addiction across alcohol, opioids, cocaine, cannabis, nicotine—and 50% fewer substance-related deaths. https://www.bmj.com/content/392/bmj-2025-086886 -
Patentudløb: Ja, det betyder meget... Men gør det ikke en forskel, 1) at volumen, der skal produceres er så absurd stor og i forlængelse 2) at der i produktionen af disse absurd store mængder API med nærmest matematisk garanti vil gå "flaskehals" i anskaffelsen af vitale kemikalier til produktionen... som med stor sandsynlighed vil bremse/forsinke/umuliggøre produktionen. Jeg kunne godt tænke mig en diskussion af dette...
-
Forskarar trur at slankemedisinen Wegovy kan hjelpe med både vekt, hukommelse og den mentale helsa.https://www.nrk.no/vestland/vil-gje-slankemedisinen-wegovy-til-psykisk-sjuke-_-trur-det-kan-hjelpe-med-vekt-og-mental-helse-1.17774454
-
ResearchPulse
@ResearchPulse1$NVO lowers price for wegovy with 17% in Spain. New price for 2.4mg will be €225 or about $265.
Ozempic and Rybelsus will see 8% and 7% reduction.
Furthermore NVO general manager in Spain, says Spain will be among the first European countries to launch wegovy pill when approved by EMA.
We don’t know the exact time NVO filed wegovy pill in Europe. But my guess is launch in Q4 this year in selected European markets.
-
Investseekers
@investseekersNew $NVO oral Wegovy prescription numbers:
This is how prescriptions have increased week over week since launch:
4,290 → 20,382 → 26,794 → 29,410 → 38,423 → 54,038 → 58,586 → 60,680.
Note: the first numbers reported in the media are usually slightly lower than the final Symphony figures.
Insured patients only. Symphony data.
-
Lederstof 6/2 “Der gik flere dage, før Lars Fruergaard kunne se videoen af Novo-medarbejdernes hyldest uden at fælde en tåre” https://www.lederstof.dk/der-gik-flere-dage-foer-lars-fruergaard-kunne-se-novo-medarbejdernes-hyldest
-
Novo Nordisks Wegovy-pille udskrives til flere målt på amerikanske recepttal https://proinvestor.com/investornyt/1418452/novo-nordisks-wegovy-pille-udskrives-til-flere-malt-pa-amerikanske-recepttal
-
GLP-1 Gold Rush Meets Legal Reality: Novo Nordisk Challenges Compounded Alternatives https://hallrender.com/2026/03/05/glp-1-gold-rush-meets-legal-reality-novo-nordisk-challenges-compounded-alternatives/
-
Enig JKY.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind